Stoichiometry of Monoclonal Antibody Neutralization of T-Cell Line-Adapted Human Immunodeficiency Virus Type 1
暂无分享,去创建一个
K. Schønning | O. Lund | Kristian Schønning | Ole Lund | Ole Søgaard Lund | John-Erik Stig Hansen | John-Erik Stig Hansen | Ole Søgaard Lund
[1] C. Wohlfart,et al. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms , 1988, Journal of virology.
[2] A. Trkola,et al. Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines , 1998, Journal of Virology.
[3] Q. Sattentau,et al. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.
[4] J. Moore,et al. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. , 1995, AIDS.
[5] J. Hansen,et al. Induction of antibodies against epitopes inaccessible on the HIV type 1 envelope oligomer by immunization with recombinant monomeric glycoprotein 120. , 1998, AIDS research and human retroviruses.
[6] P. Earl,et al. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[7] Deborah Fass,et al. Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.
[8] A. Osterhaus,et al. Modulation of primary human immunodeficiency virus type 1 envelope glycoprotein-mediated entry by human antibodies. , 1997, The Journal of general virology.
[9] R. Dulbecco,et al. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.
[10] F. Graham,et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.
[11] M. Schutten,et al. Enhancement of Infectivity of a Non‐Syncytium Inducing HIV‐1 by sCD4 and by Human Antibodies that Neutralize Syncytium Inducing HIV‐1 , 1995, Scandinavian journal of immunology.
[12] J. Moore,et al. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. , 1989, AIDS.
[13] J. Mascola,et al. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. , 1996, The Journal of infectious diseases.
[14] J. Nielsen,et al. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. , 1996, Virology.
[15] Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization , 1997, The Journal of experimental medicine.
[16] J. Hansen,et al. Inhibition of HIV type 1 infectivity by coexpression of a wild-type and a defective glycoprotein 120. , 1998, AIDS research and human retroviruses.
[17] J. Sodroski,et al. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants , 1990, Journal of virology.
[18] J. Moore,et al. Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1 , 1996, Journal of virology.
[19] C. Barbas,et al. Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies , 1998, Journal of Virology.
[20] R. Rueckert,et al. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. , 1983, Virology.
[21] L. Bacheler,et al. HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. , 1990, AIDS research and human retroviruses.
[22] B. Chesebro,et al. Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. , 1991, The Journal of infectious diseases.
[23] P. Earl,et al. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein , 1991, Journal of virology.
[24] J. Sodroski,et al. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses , 1996, Journal of virology.
[25] B. Wahrén,et al. Neutralizing cross‐reactive and non‐neutralizing monoclonal antibodies to HIV‐1 gp 120 , 1990, AIDS.
[26] S. Harrison,et al. Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.
[27] Q. Sattentau,et al. Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.
[28] Ying Sun,et al. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates , 1995, Journal of virology.
[29] Claes WOHLFARTt. Neutralization of Adenoviruses: Kinetics, Stoichiometry, and Mechanisms , 2022 .
[30] W. Anderson,et al. Functional interactions between monomers of the retroviral envelope protein complex , 1997, Journal of virology.
[31] M. Champe,et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160 , 1990, Nature.
[32] E. Wimmer,et al. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization , 1983, Journal of virology.
[33] N. Dimmock,et al. Quantitative relationships between an influenza virus and neutralizing antibody. , 1987, Virology.
[34] R. Webster,et al. Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers , 1988, The Journal of cell biology.
[35] J. Sodroski,et al. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.
[36] B. Mandel. Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. , 1976, Virology.
[37] R. Compans,et al. Evidence for Cooperation between Murine Leukemia Virus Env Molecules in Mixed Oligomers , 1998, Journal of Virology.
[38] P. Earl,et al. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain , 1990, Journal of virology.
[39] E. G. Westaway,et al. A multi-hit model for the neutralization of animal viruses. , 1978, The Journal of general virology.
[40] N. Dimmock,et al. Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. , 1994, The Journal of general virology.